Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 13, 2025, 21:08 UTC
  • 7
  • 0 comments

UTHR: Notification

Market reaction Comment Full text

Fennec Pharmaceuticals Inc (FENC)

  • Business News
  • Nov. 13, 2025, 21:08 UTC
  • 14
  • 1 comments

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

Market reaction Comment Full text

Verastem Inc (VSTM)

  • Business News
  • Nov. 13, 2025, 21:07 UTC
  • 13
  • 1 comments

Verastem Oncology Announces Proposed Public Offering of Common Stock

Market reaction Comment Full text

Tenon Medical Inc (TNON)

  • Business News
  • Nov. 13, 2025, 21:06 UTC
  • 7
  • 0 comments

Tenon® Medical Reports Third Quarter 2025 Financial Results

Market reaction Comment Full text

Equillium Inc. (EQ)

  • Business News
  • Nov. 13, 2025, 21:06 UTC
  • 7
  • 0 comments

Equillium - Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

Market reaction Comment Full text

BioAtla Inc (BCAB)

  • Business News
  • Nov. 13, 2025, 21:06 UTC
  • 6
  • 0 comments

BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Market reaction Comment Full text

Merit Medical Systems Inc (MMSI)

  • Business News
  • Nov. 13, 2025, 21:06 UTC
  • 6
  • 0 comments

Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis

Market reaction Comment Full text

Eyenovia Inc. (EYEN)

  • Business News
  • Nov. 13, 2025, 21:06 UTC
  • 6
  • 0 comments

Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million

Market reaction Comment Full text

ORIC Pharmaceuticals Inc (ORIC)

  • Business News
  • Nov. 13, 2025, 21:06 UTC
  • 5
  • 0 comments

ORIC® Pharmaceuticals Announces Completion of Dose Exploration Portion of ORIC-944 Phase 1b Clinical Trial and Continues to Demonstrate Potential Best-in-Class Efficacy and Safety

Market reaction Comment Full text

Aytu BioPharma Inc. (AYTU)

  • Business News
  • Nov. 13, 2025, 21:06 UTC
  • 6
  • 0 comments

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

Market reaction Comment Full text
  • Previous
  • 648
  • 649
  • 650
  • 651
  • 652
  • Next

Search

News categories

  • Technical Exchange News(10958)
  • Event(2424)
  • SEC News(192920)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125654)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin